# Rising Substance Use Among Gen Z in Their Early Twenties > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/substance-use-trends-gen-z-early-twenties/ > **Published:** 2026-04-24T16:46:24-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:11:22-04:00 > **Clinical Summary:** Explore substance use trends Gen Z in their early twenties, highlighting increased cannabis and drug use and clinical implications for young adults. --- โœฆ New CED Clinical Relevance** #40 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. ResearchMental HealthSafetyPolicy Clinical Summary A recent analysis of substance use trends reveals that individuals in Generation Z are reporting increased [cannabis and other drug use](https://cedclinic.com/cannabis-use-other-illicit-drugs-16-year-study/) as they enter their early twenties, a period critical for brain development and establishment of health behaviors. This population-level shift has significant implications for clinicians who encounter Gen Z patients, as early and escalating cannabis use is associated with risks including [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/), mental health complications, and potential cannabis use disorder. The findings underscore the importance of routine substance use screening in young adult patients, particularly given the normalization and increased availability of cannabis products in many jurisdictions. Clinicians should be prepared to address cannabis use with this demographic using evidence-based counseling approaches and to recognize that age-appropriate risk messaging may need adjustment as perceptions of [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) evolve among younger cohorts. Understanding these epidemiologic patterns helps contextualize individual patient behaviors and informs counseling about the neurodevelopmental risks specific to young adult users. Clinicians caring for Gen Z patients should integrate proactive cannabis use assessment into routine visits and be equipped to discuss the particular vulnerabilities of this age group to cannabis-related harms. Clinical Perspective Rising substance use among young adults in their early twenties warrants heightened clinical vigilance, particularly given that this cohort has grown up with increased cannabis availability and normalization. Healthcare providers should recognize that cannabis use in this population may co-occur with other substance use patterns and mental health conditions, complicating both diagnosis and management. The timing of early twenties is developmentally sensitive for brain maturation, particularly prefrontal regions involved in decision-making and impulse control, making substance use screening especially important during preventive care visits. When counseling young adults about cannabis, clinicians should discuss both population-level trends and individual risk factors, while acknowledging that perceived safety and legal status in some regions may influence patient disclosure and attitudes. In practice, incorporating brief substance use screening into routine care and maintaining a non-judgmental stance may improve opportunities to identify problematic patterns early and provide motivational interviewing or referral to evidence-based interventions when ๐Ÿ’ฌ Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan โ†’](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion โ†’](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [๐• Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Substance+use+on+the+rise+among+Gen+Z+in+their+early+20s+-+Medical+Xpress+%40drcaplan&url=https%3A%2F%2Fmedicalxpress.com%2Fnews%2F2026-03-substance-gen-early-20s.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fmedicalxpress.com%2Fnews%2F2026-03-substance-gen-early-20s.html)[๐Ÿฆ… Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Substance+use+on+the+rise+among+Gen+Z+in+their+early+20s+-+Medical+Xpress+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fmedicalxpress.com%2Fnews%2F2026-03-substance-gen-early-20s.html)[๐Ÿ“ท Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[๐Ÿ“ Read more on Substack](https://substack.com/@doctorapproved)[๐Ÿ”” Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Study**: Teen **cannabis** use doubles risk for psychotic and bipolar disorders โ€“ USC Price](https://cedclinic.com/teen-cannabis-psychotic-disorder-risk-usc-study/) - [Cooney introduces bill to allow selling of low-potency cannabis beverages at liquor and wine stores](https://cedclinic.com/low-dose-thc-beverages-bill-new-york/) - [**Study** Published in Pediatrics Finds Infrequent **Cannabis** Use Can Impact Adolescent โ€ฆ](https://cedclinic.com/study-published-in-pediatrics-finds-infrequent-cannabis-use-can-impact-adolescent/) ๐Ÿ“ฐ Source: [https://medicalxpress.com/news/2026-03-substance-gen-early-20s.html](https://medicalxpress.com/news/2026-03-substance-gen-early-20s.html) Further Reading CED Clinic Blog[What the DOJ Cannabis Order Means for Patients and Clinicians](https://cedclinic.com/medical-cannabis-schedule-iii-order/) Research Digest[Research Digest: 10 Recent Studies โ€“ April 22, 2026](https://cedclinic.com/recent-cannabinoid-clinical-research-april-2026/) Evidence Watch[Mechanistic Pathways Linking Cannabidiol, Hemp Seed Oil and Black Sesame Oil in Hyperarousal Insomnia: A Narrative Review.](https://cedclinic.com/mechanistic-pathways-insomnia-cbd-hemp-sesame-oil/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [New Research Highlights Growing Concerns Around Cannabis Use Among Young Adults](https://cedclinic.com/cannabis-use-disorder-young-adults-concerns/) This article discusses recent findings on cannabis use patterns and concerns in young adult populations. [Read More](https://cedclinic.com/cannabis-use-disorder-young-adults-concerns/) [The Best CBD for Mental Clarity and Focus in 2026](https://cedclinic.com/best-cbd-for-mental-clarity-2026-focus-stupiddope/) Explore top [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) that support mental clarity and focus, relevant for young adults managing substance use. [Explore Now](https://cedclinic.com/best-cbd-for-mental-clarity-2026-focus-stupiddope/) [Buy GREEN: A Field Guide To Marijuana Each Book Online](https://cedclinic.com/buy-marijuana-field-guide-online-green-cannabis-book/) A comprehensive guide to marijuana, offering insights into cannabis use and its effects for educational purposes. [Get the Guide](https://cedclinic.com/buy-marijuana-field-guide-online-green-cannabis-book/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR ยง 164.514(b)) and criteria for secondary research exemption under 45 CFR ยง 46.104(d)(4).